Active Biotech Q2’21: Encouraging Signals from Partnered Project
Redeye has a positive view on the recent report from the partnered NAP project and the expected news flow from the project portfolio during the remainder of 2021.
NE
Niklas Elmhammer
Disclosures and disclaimers